Joshua Korsen

Joshua Korsen, PhD, is currently an Equity Research Associate specializing in Biotechnology at H.C. Wainwright & Co., LLC since November 2022. Prior experience includes serving as a Doctoral Student at Memorial Sloan Kettering Cancer Center from August 2017 to August 2022, where doctoral research was conducted under Dr. Jason Lewis. Joshua also held the position of Biotech Equity Research Analyst at The Solution Lab, Inc. in 2021, focusing on immuno-oncology analysis and investor engagement. Teaching experience spans roles as a Teaching Assistant in Pharmacology at Weill Cornell and in Organic Chemistry at Brandeis University, along with undergraduate research assistant positions. Joshua Korsen earned a PhD in Pharmacology from Weill Cornell Graduate School and a Bachelor of Science in Chemistry and Biology from Brandeis University.